165 related articles for article (PubMed ID: 3032213)
1. Peptide vaccine--a new approach to a safer foot-and-mouth disease virus vaccine.
Pfaff E; Thiel HJ; Böhm HO; Leban J
Arzneimittelforschung; 1987 Jan; 37(1):82-6. PubMed ID: 3032213
[TBL] [Abstract][Full Text] [Related]
2. Synthetic peptides against foot-and-mouth disease--immunization with VP1-peptides of type O1-Kaufbeuren.
Liebermann H; Holl U; Reimann I; Nöckler A; Schäfer D; Thalmann G; Dölling R
Arch Exp Veterinarmed; 1990; 44(6):883-90. PubMed ID: 1966360
[TBL] [Abstract][Full Text] [Related]
3. Escape mutants of foot-and-mouth disease virus selected by monoclonal antibodies directed to a trypsin-sensitive neutralization epitope.
Das BR; Pattnaik B; Venkataramanan R; Rai DV
Acta Virol; 1997 Jun; 41(3):131-8. PubMed ID: 9385400
[TBL] [Abstract][Full Text] [Related]
4. Orally delivered foot-and-mouth disease virus capsid protomer vaccine displayed on T4 bacteriophage surface: 100% protection from potency challenge in mice.
Ren ZJ; Tian CJ; Zhu QS; Zhao MY; Xin AG; Nie WX; Ling SR; Zhu MW; Wu JY; Lan HY; Cao YC; Bi YZ
Vaccine; 2008 Mar; 26(11):1471-81. PubMed ID: 18289743
[TBL] [Abstract][Full Text] [Related]
5. [Antigenic structure of the foot-and-mouth-disease virus. I. Synthesis of protective peptides from the major immunogenic region of VP1 protein of foot-and-mouth virus type O1K].
Surovoĭ AIu; Vol'pina OM; Snetkova EV; Volkova TD; Ivanov VT
Bioorg Khim; 1988 Oct; 14(10):1352-62. PubMed ID: 2852937
[TBL] [Abstract][Full Text] [Related]
6. [Antigenic structure of the foot-and-mouth disease virus. II. Synthesis of protective peptides from the major immunogenic region of VP1 protein of foot-and-mouth disease virus type A22].
Vol'pina OM; Surovoĭ AIu; Ul'iashin VV; Ivanov VT; Chepurkin AV
Bioorg Khim; 1988 Oct; 14(10):1363-71. PubMed ID: 2852938
[TBL] [Abstract][Full Text] [Related]
7. A 10-amino-acid linear sequence of VP1 of foot and mouth disease virus containing B- and T-cell epitopes induces protection in mice.
Zamorano P; Wigdorovitz A; Perez-Filgueira M; Carrillo C; Escribano JM; Sadir AM; Borca MV
Virology; 1995 Oct; 212(2):614-21. PubMed ID: 7571431
[TBL] [Abstract][Full Text] [Related]
8. Immune responses of recombinant adenovirus co-expressing VP1 of foot-and-mouth disease virus and porcine interferon alpha in mice and guinea pigs.
Du Y; Dai J; Li Y; Li C; Qi J; Duan S; Jiang P
Vet Immunol Immunopathol; 2008 Aug; 124(3-4):274-83. PubMed ID: 18511133
[TBL] [Abstract][Full Text] [Related]
9. Protection of mice against challenge with foot and mouth disease virus (FMDV) by immunization with foliar extracts from plants infected with recombinant tobacco mosaic virus expressing the FMDV structural protein VP1.
Wigdorovitz A; Pérez Filgueira DM; Robertson N; Carrillo C; Sadir AM; Morris TJ; Borca MV
Virology; 1999 Nov; 264(1):85-91. PubMed ID: 10544132
[TBL] [Abstract][Full Text] [Related]
10. The potential of retro-inverso peptides as synthetic vaccines.
Van Regenmortel MH; Guichard G; Benkirane N; Briand JP; Muller S; Brown F
Dev Biol Stand; 1998; 92():139-43. PubMed ID: 9554267
[TBL] [Abstract][Full Text] [Related]
11. Recognition of B and T cell epitopes by cattle immunized with a synthetic peptide containing the major immunogenic site of VP1 FMDV 01 Campos.
Zamorano P; Wigdorovitz A; Chaher MT; Fernandez FM; Carrillo C; Marcovecchio FE; Sadir AM; Borca MV
Virology; 1994 Jun; 201(2):383-7. PubMed ID: 8184548
[TBL] [Abstract][Full Text] [Related]
12. [Antigenic structure of the foot-and-mouth disease virus. III. Immunogenic properties of synthetic peptides of the sequence of the immunodominant region of VP1 proteins of the O1K and A22 strains of foot-and-mouth virus].
Surovoĭ AIu; Gel'fanov VM; Vol'pina OM; Ivanov VT; Chepurkin AV; Chepurkin AV; Ivaniushchenkov VM; Driagalin NN; Burdov AN
Bioorg Khim; 1989 Sep; 15(9):1185-92. PubMed ID: 2480134
[TBL] [Abstract][Full Text] [Related]
13. Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate.
Mayr GA; Chinsangaram J; Grubman MJ
Virology; 1999 Oct; 263(2):496-506. PubMed ID: 10544121
[TBL] [Abstract][Full Text] [Related]
14. Enhanced immunogenicity and cross-reactivity of retro-inverso peptidomimetics of the major antigenic site of foot-and-mouth disease virus.
Muller S; Guichard G; Benkirane N; Brown F; Van Regenmortel MH; Briand JP
Pept Res; 1995; 8(3):138-44. PubMed ID: 7670228
[TBL] [Abstract][Full Text] [Related]
15. Antibodies elicited by a biosynthetic peptide related to a major immunogenic area of FMDV A12.
Borca MV; Moore DM; Srikumaran S; Morgan DO
Viral Immunol; 1990; 3(2):147-60. PubMed ID: 1694429
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity of a recombinant fusion protein of tandem repeat epitopes of foot-and-mouth disease virus type Asia 1 for guinea pigs.
Zhang Q; Yang YQ; Zhang ZY; Li L; Yan WY; Jiang WJ; Xin AG; Lei CX; Zheng ZX
Acta Virol; 2002; 46(1):1-9. PubMed ID: 12199204
[TBL] [Abstract][Full Text] [Related]
17. Comparison of immune responses against foot-and-mouth disease virus induced by fusion proteins using the swine IgG heavy chain constant region or beta-galactosidase as a carrier of immunogenic epitopes.
Li G; Chen W; Yan W; Zhao K; Liu M; Zhang J; Fei L; Xu Q; Sheng Z; Lu Y; Zheng Z
Virology; 2004 Oct; 328(2):274-81. PubMed ID: 15464847
[TBL] [Abstract][Full Text] [Related]
18. [Antigenic structure of the foot-and-mouth virus. VI. Functional segments of the immunodominant region of the VP1 protein of foot-and-mouth virus strains O1K and A22].
Gel'famov VM; Grechaninova LA; Kan ES; Iarov AV; Surovoĭ AIu; Vol'pina OM; Chepurkin AV; Ivanov VT
Bioorg Khim; 1991 May; 17(5):596-605. PubMed ID: 1722673
[TBL] [Abstract][Full Text] [Related]
19. Protection against viral infections with the aid of synthetic peptides. Foot-and-mouth disease as an example.
Vol'pina OM; Surovoi AYu ; Ivanov VT
Biomed Sci; 1990 Jan; 1(1):23-32. PubMed ID: 1718462
[TBL] [Abstract][Full Text] [Related]
20. Synthetic peptide vaccines: foot-and-mouth disease virus as a model.
Sobrino F; Blanco E; García-Briones M; Ley V
Dev Biol Stand; 1999; 101():39-43. PubMed ID: 10566773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
